Required.
A Certificate of Analysis (COA) is required under R9-17-317.01 and R9-17-314, which mandate that all medical marijuana or marijuana products be tested and labeled with results before being dispensed to patients.
Required. Arizona requires testing for the following cannabinoids (see Table 3.1 on p. 36):
Required under R9-17-317.01 for products labeled with terpene content. Commonly required terpenes include:
(Though not all products are required to include terpene content, if claimed, they must be tested and listed.)
Pesticides
Microbial contaminants
Mycotoxins
Heavy metals
Foreign materials – Testing includes visual inspection and physical integrity (R9-17-317.01 and R9-17-404.04).
(Arizona requires screening for Lead, Arsenic, Cadmium, and Mercury.)
Medium Concern – Arizona has a broad test panel, but gaps remain in mycotoxin and microbial pathogen testing, and not all high-risk pesticides are covered
Required.
Moisture content and water activity testing is required to limit microbial growth and ensure product stability per R9-17-317.01 (and laboratory procedures in R9-17-404).
Arizona Department of Health Services – Medical Marijuana Program
Website: https://www.azdhs.gov
Contact Name: Megan Whitby, Bureau Chief
Phone: (602) 364-3052
Email: Megan.Whitby@azdhs.gov
Address: 150 N. 18th Ave., Suite 400, Phoenix, AZ 85007
Arizona Department of Health Services. (2021). Arizona Administrative Code Title 9, Chapter 17
Cannabis Cate
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.